Joan Merrill to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications Joan Merrill has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.412
-
What was wrong and might now go right with clinical trials for lupus? Curr Rheumatol Rep. 2009 Aug; 11(4):235-7.
Score: 0.338
-
Clinical trial parameters that influence outcomes in lupus trials that use the systemic lupus erythematosus responder index. Rheumatology (Oxford). 2018 01 01; 57(1):125-133.
Score: 0.038
-
Brief Report: Longitudinal Patterns of Response to Standard of Care Therapy for Systemic Lupus Erythematosus: Implications for Clinical Trial Design. Arthritis Rheumatol. 2017 04; 69(4):785-790.
Score: 0.036